Desdifluoro Dolutegravir-d7
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Desdifluoro Dolutegravir-d7 Product Information
Desdifluoro Dolutegravir-d7 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96369.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Desdifluoro Dolutegravir-d7
CAT No.
CS-T-96369
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C20H14D7N3O5
Molecular Weight
390.44
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Desdifluoro Dolutegravir-d7 is supplied with detailed characterization data compliant with regulatory guideline. Desdifluoro Dolutegravir-d7 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Desdifluoro Dolutegravir-d7 is impurity B of Dolutegravir (D528800), which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector."
Synonyms
Desdifluoro Dolutegravir-d7
Application Notes
"Desdifluoro Dolutegravir-d7 is impurity B of Dolutegravir (D528800), which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.